A detailed history of Lpl Financial LLC transactions in Amgen Inc stock. As of the latest transaction made, Lpl Financial LLC holds 751,945 shares of AMGN stock, worth $221 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
751,945
Previous 746,946 0.67%
Holding current value
$221 Million
Previous $233 Million 3.81%
% of portfolio
0.11%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$309.38 - $337.38 $1.55 Million - $1.69 Million
4,999 Added 0.67%
751,945 $242 Million
Q2 2024

Aug 07, 2024

BUY
$262.75 - $319.31 $17.6 Million - $21.4 Million
66,983 Added 9.85%
746,946 $233 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $16.9 Million - $20.4 Million
-62,949 Reduced 8.47%
679,963 $193 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $3.4 Million - $3.84 Million
-13,297 Reduced 1.76%
742,912 $214 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $10.9 Million - $13.5 Million
49,871 Added 7.06%
756,209 $203 Million
Q2 2023

Jul 31, 2023

BUY
$214.27 - $253.37 $18.1 Million - $21.3 Million
84,249 Added 13.54%
706,338 $157 Million
Q1 2023

May 10, 2023

BUY
$225.79 - $275.2 $12.1 Million - $14.7 Million
53,577 Added 9.42%
622,089 $150 Million
Q4 2022

Feb 07, 2023

SELL
$229.03 - $291.01 $982,767 - $1.25 Million
-4,291 Reduced 0.75%
568,512 $149 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $11.9 Million - $13.4 Million
52,882 Added 10.17%
572,803 $129 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $9.62 Million - $10.7 Million
41,716 Added 8.72%
519,921 $126 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $5.56 Million - $6.16 Million
25,375 Added 5.6%
478,205 $116 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $4.08 Million - $4.67 Million
20,500 Added 4.74%
452,830 $102 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $934,200 - $1.09 Million
4,401 Added 1.03%
432,330 $91.9 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $4.21 Million - $4.67 Million
18,038 Added 4.4%
427,929 $104 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $4.33 Million - $5.04 Million
19,503 Added 5.0%
409,891 $102 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $8.18 Million - $9.74 Million
37,792 Added 10.72%
390,388 $89.8 Million
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $4.09 Million - $4.55 Million
17,422 Added 5.2%
352,596 $89.6 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $4.11 Million - $5.04 Million
20,759 Added 6.6%
335,174 $79.1 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $5.58 Million - $7.4 Million
30,625 Added 10.79%
314,415 $63.7 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $6.89 Million - $8.86 Million
36,427 Added 14.73%
283,790 $68.4 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $610,081 - $731,004
-3,504 Reduced 1.4%
247,363 $47.9 Million
Q2 2019

Aug 09, 2019

BUY
$166.7 - $195.41 $5.62 Million - $6.58 Million
33,695 Added 15.52%
250,867 $46.2 Million
Q1 2019

May 08, 2019

BUY
$180.87 - $203.88 $2.05 Million - $2.32 Million
11,359 Added 5.52%
217,172 $41.3 Million
Q4 2018

Feb 07, 2019

BUY
$178.4 - $208.25 $2.11 Million - $2.47 Million
11,848 Added 6.11%
205,813 $40.1 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $1.54 Million - $1.73 Million
8,300 Added 4.47%
193,965 $40.2 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $562,743 - $632,082
3,389 Added 1.86%
185,665 $34.3 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $5.28 Million - $6.18 Million
31,188 Added 20.64%
182,276 $31.1 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $1.44 Million - $1.61 Million
8,536 Added 5.99%
151,088 $26.3 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $1.01 Million - $1.16 Million
6,059 Added 4.44%
142,552 $26.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
136,493
136,493 $23.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.